High-Intensity Interval Training Reduces Liver Enzyme Levels and Improves MASLD-Related Biomarkers in Overweight/Obese Girls
Nutrients · 2025
DOI: 10.3390/nu17010164 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Wissal Abassi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit "Sport Sciences, Health and Movement" (UR22JS01), High Institute of Sport and Physical Education of Kef, University of Jendouba, Kef 71…. Hauptthemen laut MEDLINE: High-Intensity Interval Training, Pediatric Obesity, Liver, Overweight. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Despite the abundant body of evidence linking high-intensity interval training (HIIT) to cardiometabolic markers, little is known about how HIIT affects liver enzymes, particularly in obese adolescents. This study aimed to investigate the effects of HIIT on metabolic dysfunction-associated steatotic liver disease (MASLD)-related biomarkers in overweight/obese adolescent girls.
Methods
Thirty-three overweight/obese adolescent girls (age, 17.0 ± 1.15 yr.; body mass index, 33.3 ± 4.77 kg/m2) were randomly assigned to HIIT (n = 17) or control (n = 16) groups. The HIIT group participated in a nine-week HIIT program (three times weekly) without caloric restriction. Maximal aerobic speed, body composition indexes, blood pressure, MASLD-related biomarkers [liver enzymes (alanine aminotransferase (ALT) and aspartate aminotransferase (AST)), plasma lipids, uric acid, platelet count, and homeostasis model assessment index for insulin-resistance (HOMA-IR)] were examined at baseline and after the intervention.
Results
Significant “time × group” interactions were found for body composition indexes, systolic blood pressure, maximal aerobic speed, liver enzymes ALT and AST, plasma lipids, glucose, and HOMA-IR. The HIIT program resulted in an increase in maximal aerobic speed (p = 0.035) and a decrease in body composition and plasma lipids (p < 0.01), systolic blood pressure (p = 0.011), ALT (p = 0.013), AST (p = 0.012), and HOMA-IR (p = 0.01), but no significant changes in uric acid and platelet count. None of these markers changed in the control group.
Conclusions
HIIT resulted in an improvement in MASLD-related biomarkers. HIIT could be an effective exercise therapy to prevent and reverse MASLD in adolescents with obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Unit "Sport Sciences, Health and Movement" (UR22JS01), High Institute of Sport and Physical Education of Kef, University of Jendouba, Kef 7100, Tunisia.
- Faculty of Medicine of Tunis, Rabta Hospital, LR99ES11, University of Tunis El Manar, Tunis 1007, Tunisia.
- High Institute of Sport and Physical Education of Gafsa, University of Gafsa, Gafsa 2100, Tunisia.
- Institute of Primary Care, University of Zurich, 8091 Zurich, Switzerland.
- Medbase St. Gallen Am Vadianplatz, 9000 St. Gallen, Switzerland.
ORCID-Profile: Nejmeddine Ouerghi, Mohamed Bessem Hammami, Nidhal Jebabli, Moncef Feki, Katja Weiss, Beat Knechtle
Zitieren
APA
Abassi, W., Ouerghi, N., Hammami, M. B., Jebabli, N., Feki, M., Bouassida, A., Weiss, K., & Knechtle, B. (2025). High-Intensity Interval Training Reduces Liver Enzyme Levels and Improves MASLD-Related Biomarkers in Overweight/Obese Girls. Nutrients. https://doi.org/10.3390/nu17010164
Vancouver
Abassi W, Ouerghi N, Hammami MB, Jebabli N, Feki M, Bouassida A, et al. High-Intensity Interval Training Reduces Liver Enzyme Levels and Improves MASLD-Related Biomarkers in Overweight/Obese Girls. Nutrients. 2025. doi:10.3390/nu17010164
BibTeX
@article{Abassi2025,
author = {Abassi, Wissal and Ouerghi, Nejmeddine and Hammami, Mohamed Bessem and Jebabli, Nidhal and Feki, Moncef and Bouassida, Anissa and Weiss, Katja and Knechtle, Beat},
title = {High-Intensity Interval Training Reduces Liver Enzyme Levels and Improves MASLD-Related Biomarkers in Overweight/Obese Girls},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17010164}
}
EUVIMED